The reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.54BILS
5.20B · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
503.09MILS
168.38M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-70.17%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -77.64%.Updated Aug 21, 2026
Beta
1.25x
vs all stocks
Updated Aug 21, 2026
52-Week Change
319.04%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
15.54BILS
5.20B · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
15.58BILS
5.21B · vs all stocks (USD)
Updated Aug 21, 2026
Price to Sales (TTM)
26.05x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 30.89×.Updated Aug 21, 2026
Price to Book (MRQ)
6.34x
Updated Aug 21, 2026
Enterprise to Revenue
30.54x
Updated Aug 21, 2026
Gross Margin
3.59%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 13.96%.Updated Aug 21, 2026
Profit Margin
-70.17%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -77.64%.Updated Aug 21, 2026
Operating Margin
-29.43%
Updated Aug 21, 2026
Return on Assets (TTM)
-0.97%
Updated Aug 21, 2026
Return on Equity (TTM)
-20.67%
Updated Aug 21, 2026
Revenue (TTM)
503.09MILS
168.38M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
2.80ILSUpdated Aug 21, 2026
Quarterly Revenue Growth
47.00%
Updated Aug 21, 2026
Gross Profit (TTM)
70.21MILS
23.50M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-390.60MILS
-130.73M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
46.99%
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-82.90MILS
-27.75M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-390.60MILS
-130.73M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing Annual Dividend Rate
0.00ILSUpdated Aug 21, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
0.00%
Updated Aug 21, 2026
Minority Interest (Equity)
-12.05MILSFY2025 · Dec 31, 2025
Revenue
503.09MILSFY2025 · Dec 31, 2025
Cost of Goods Sold
432.88MILSFY2025 · Dec 31, 2025
Gross Profit
70.21MILSFY2025 · Dec 31, 2025
Operating Income
-95.66MILS
-32.02M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-474.65MILSFY2025 · Dec 31, 2025
Income Tax Expense
-54.56MILSFY2025 · Dec 31, 2025
Net Income
-420.09MILSFY2025 · Dec 31, 2025
EBIT
-237.17MILSFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-44.25MILSFY2025 · Dec 31, 2025
Research & Development
2.85MILSFY2025 · Dec 31, 2025
Selling, General & Administrative
64.08MILSFY2025 · Dec 31, 2025
Other Operating Expenses
6.29MILSFY2025 · Dec 31, 2025
Non-operating Interest Income
100.79MILSFY2025 · Dec 31, 2025
Non-operating Interest Expense
237.48MILSFY2025 · Dec 31, 2025
EPS (Basic)
-2.18ILSFY2025 · Dec 31, 2025
EPS (Diluted)
-2.18ILSFY2025 · Dec 31, 2025
Basic Shares Outstanding
179.41MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
179.41MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-420.09MILSFY2025 · Dec 31, 2025
Minority Interests (P&L)
29.48MILSFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00ILSFY2025 · Dec 31, 2025
Operating Cash Flow
-210.04MILSFY2025 · Dec 31, 2025
Free Cash Flow
-837.35MILSFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.09BILSFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-420.09MILSFY2025 · Dec 31, 2025
Stock-based Compensation
4.15MILSFY2025 · Dec 31, 2025
Other Non-cash Items
220.67MILSFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-14.78MILSFY2025 · Dec 31, 2025
Capital Expenditures
-627.31MILSFY2025 · Dec 31, 2025
Net Acquisitions
8.59MILSFY2025 · Dec 31, 2025
Purchase of Investments
-400.21MILSFY2025 · Dec 31, 2025
Sale of Investments
1.79MILSFY2025 · Dec 31, 2025
Other Investing Activity
30.71MILSFY2025 · Dec 31, 2025
Net Investing Cash Flow
-986.42MILSFY2025 · Dec 31, 2025
Long-term Debt Issuance
367.92MILSFY2025 · Dec 31, 2025
Long-term Debt Payments
-74.46MILSFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-436.17MILSFY2025 · Dec 31, 2025
Other Financing Charges
1.22BILSFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.66BILSFY2025 · Dec 31, 2025
Shares Outstanding
199.66MSharesUpdated Aug 21, 2026
Float Shares
109.94MSharesUpdated Aug 21, 2026
% Held by Insiders
40.82%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
29.61%
vs all stocks
Updated Aug 21, 2026
Total Cash per Share (MRQ)
7.71ILSUpdated Aug 21, 2026
Total Debt (MRQ)
5.24BILS
1.75B · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
2.55x
Updated Aug 21, 2026
Current Ratio (MRQ)
2.38x
Updated Aug 21, 2026
Book Value per Share (MRQ)
9.98ILSUpdated Aug 21, 2026
Total Assets
7.05BILS
2.36B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.51BILSFY2025 · Dec 31, 2025
Total Liabilities
5.07BILSFY2025 · Dec 31, 2025
Total Non-current Assets
5.54BILSFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.31BILSFY2025 · Dec 31, 2025
Total Current Liabilities
759.11MILSFY2025 · Dec 31, 2025
Cash
45.09MILSFY2025 · Dec 31, 2025
Cash Equivalents
1.05BILSFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.09BILSFY2025 · Dec 31, 2025
Other Short-term Investments
30.25MILSFY2025 · Dec 31, 2025
Accounts Receivable
78.57MILSFY2025 · Dec 31, 2025
Accounts Payable
95.90MILSFY2025 · Dec 31, 2025
Short-term Debt
581.86MILSFY2025 · Dec 31, 2025
Long-term Debt
4.17BILSFY2025 · Dec 31, 2025
Other Non-current Liabilities
532.00KILSFY2025 · Dec 31, 2025
Common Stock (Book)
0.00ILSFY2025 · Dec 31, 2025
Retained Earnings
678.99MILSFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.98BILS
662.77M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
1.50KILAUpdated Aug 21, 2026
52-Week High
10.45KILAUpdated Aug 21, 2026
52-Week Change
319.04%
vs all stocks
Updated Aug 21, 2026
Beta
1.25x
vs all stocks
Updated Aug 21, 2026
50-Day MA
7.09KILAUpdated Aug 21, 2026
200-Day MA
5.75KILAUpdated Aug 21, 2026
Avg 10-Day Volume
568.49KSharesUpdated Aug 21, 2026
Avg 30-Day Volume
518.50KSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-1.90ILSUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Long-Term Debt A High Share Of Total Liabilities, Short-Term Debt A High Share Of Current Liabilities
Borrowing makes up most of what it owes, both the long-dated part and the part due soon.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.06: grey zoneSignificant
Altman Z-Score: 2.06
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Market cap is $5.2B, above the global median of $1.18BNotable
Market cap (USD): 5,200,946,615.122Global Median: 1,179,398,897.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Long-Term Debt A High Share Of Total Liabilities, Short-Term Debt A High Share Of Current LiabilitiesUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Long-Term Debt A High Share Of Total Liabilities, Short-Term Debt A High Share Of Current LiabilitiesUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Long-Term Debt A High Share Of Total Liabilities, Short-Term Debt A High Share Of Current LiabilitiesUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated